By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ContraFect Corporation 

28 Wells Avenue, Third Floor

Yonkers  New York   10701  U.S.A.
Phone: 914-207-2300 Fax: n/a



Company News
ContraFect Corporation (CFRXU) Receives FDA Approval to Initiate Clinical Trials of CF-301 for MRSA Bloodstream Infections 12/22/2014 7:23:14 AM
ContraFect Corporation (CFRXU) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014 2:42:47 PM
ContraFect Corporation (CFRXU) Submits Complete Response To IND Clinical Hold For CF-301 12/2/2014 12:10:05 PM
ContraFect Corporation (CFRXU) Announces Third Quarter 2014 Results 11/18/2014 5:00:15 PM
ContraFect Corporation (CFRXU) And China's IVDC Collaborate On Universal Flu Treatment 10/10/2014 12:22:00 PM
ContraFect Corporation (CFRXU) And National Institute For Viral Disease Control And Prevention, China CDC Sign Agreement To Collaborate On Universal Influenza Treatment 10/9/2014 9:47:06 AM
ContraFect Corporation (CFRXU) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2014 10:01:31 AM
ContraFect Corporation (CFRXU) Expands Senior Management Team 9/24/2014 11:49:05 AM
ContraFect Corporation (CFRXU) To Present At BioCentury's 21st Annual NewsMakers In The Biotech Industry Conference 9/22/2014 1:35:20 PM
ContraFect Corporation (CFRXU)'s Universal Influenza Treatment Receives SBIR Funding 9/17/2014 12:35:55 PM